Navigation Links
DiagnoCure announces second quarter 2008 results
Date:6/13/2008

Significant development towards the commercialization of Previstage(TM) GCC

and royalties from the sales of the PCA3 test in progress

QUEBEC CITY, June 13 /PRNewswire-FirstCall/ - DiagnoCure Inc. (TSX: CUR), a life sciences company commercializing high-value cancer diagnostic tests and delivering lab services, announced a net loss of $3,372,374 or $0.08 per share for the second quarter ending April 30, 2008. These results are substantially in line with Management expectations. They reflect the significant progress towards the commercialization of DiagnoCure's new Previstage(TM) GCC Colorectal Cancer Staging Test, and royalties of the sales of the PCA3 test progressing over last year second quarter. At the end of the quarter, cash, short-term investments and long-term investments stood at $26,691,514.

DiagnoCure also announces that, effective June 13, 2008, Mr. Alain Rheaume will succeed to Mr. Paul Gobeil as Chairman of the Board of directors of the Company. Mr. Rheaume is Founder and Managing Partner of Trio Capital Inc. He cumulates over 30 years of experience in management in both the public and private sectors. He has been Director of DiagnoCure's Board and a member of the Audit Committee since 2005.

Mr. Gobeil asked to be relieved of his duties as Chairman of the Board. The Company will continue to enjoy his broad experience as he pursues his 10-year tenure as a DiagnoCure Board member. Under Mr. Gobeil's remarkable Chairmanship since 2005, the Board has implemented a rigorous corporate governance program, ensured the hiring and transition of a new Chief Executive Officer, and completed an extensive review of the strategic foundation of the Company which translated into a new financing of $25 million, the acquisition of five promising markers and products, and the upcoming launch of a new test for colorectal cancer through the Company's new clinical laboratory in the United States.

Highlights of the Quarter


'/>"/>
SOURCE DIAGNOCURE INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. DiagnoCures molecular diagnostic tests - PCA3 and GCC - discussed at scientific meetings
2. DiagnoCure to host Q2 2008 earnings conference call and webcast
3. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
4. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
5. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
6. HEI, Inc. Announces Sale of RFID Division Assets
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
9. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
10. Brooke Franchise Corporation Announces Selected July Results
11. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... (PRWEB) May 05, 2015 May is National ... the Institute for Better Bone Health . Founded by ... aims to educate both consumers and physicians about the latest ... of bone health. , According to a study recently published ... total Americans are affected by osteoporosis and low bone mass. ...
(Date:5/5/2015)... May 05, 2015 Care ... guidebook called “Medicare Breakeven Challenges? A Model ... includes:, ,     Formulas for two ... measuring but should be ,     A ... “white space” and ensures sustained efficient operations ...
(Date:5/5/2015)... After conducting a nationwide executive search ... West Holt Medical Services in Atkinson, Neb., ... skilled healthcare executive with more than 10 years of ... June 1st. , “Brad brings a proven track record ... and success in building strong relationships with physicians,” said ...
(Date:5/5/2015)... McMunn Associates , a leader in ... today that it has officially launched a new web ... president and founder, Larry McMunn, the new web site ... for growth and expansion for the next several decades. ... years by building close, personal relationships with clients. McMunn ...
(Date:5/5/2015)... 2015 Swiftwick, a leading athletic performance ... a presenting sponsor. The partnership launched May 3, 2015, ... The COLORDASH is an innovative, untimed community race where ... by the COLORDASH. At each kilometer of the race, ... “let the color move them.” , The organization demonstrates ...
Breaking Medicine News(10 mins):Health News:The Institute for Better Bone Health Observes National Osteoporosis Month, Celebrates Three Years of Promoting Healthy Bones 2Health News:The Institute for Better Bone Health Observes National Osteoporosis Month, Celebrates Three Years of Promoting Healthy Bones 3Health News:Care Logistics Publishes a New Hospital Guidebook for Achieving Medicare Breakeven 2Health News:West Holt Medical Services Hires New Chief Executive Officer 2Health News:West Holt Medical Services Hires New Chief Executive Officer 3Health News:McMunn Associates Launches New Corporate Branding with New Website 2Health News:Swiftwick Partners with COLORDASH as Presenting Sponsor 2
... in mice pinpoints role of gene mutation in triggering ... Scientists believe they may have found the biological trigger ... In the March 12 issue of Neuron ... increased levels of the neurotransmitter glutamate in the brain ...
... 11 The Coalition for Ethical Imaging (CEI), a ... practices in Texas, has announced its support for Senate ... companion bill in the House, House Bill 2599 by ... imaging patient care and safety in the state of ...
... a leading provider of the flu shot across the nation, has ... ... (Vocus) March 11, 2009-- Nationwide Medical/Surgical, a leading provider of ... a preservative-free flu vaccine ., , ,The influenza virus, more ...
... Calif., March 11 MAP Pharmaceuticals, Inc. (Nasdaq: ... the Cowen and Company 29th Annual Health Care Conference on ... MA.A live webcast of the presentation will be available on ... http://www.mappharma.com . A replay will also be available within 24 ...
... have pinpointed a cellular pathway that determines whether ... their development. When this pathway, known as PI3K ... and proliferate independent of the amount of food ... tumors respond to dietary restrictiondefined as food consumption ...
... changing needs of Philadelphia seniorsPHILADELPHIA, March 11 ... senior care services, NewCourtland has announced plans to ... homes to AristaCare Health Services. The transaction will ... living options and community-based programming for seniors. AristaCare ...
Cached Medicine News:Health News:Clues Found to Brain Mechanism Behind Migraines 2Health News:The Coalition for Ethical Imaging Announces Support for Diagnostic Imaging Bills Introduced in Texas Legislature 2Health News:The Coalition for Ethical Imaging Announces Support for Diagnostic Imaging Bills Introduced in Texas Legislature 3Health News:Nationwide Medical/Surgical Announces Preservative Free Flu Vaccine Available 2Health News:Cell pathway on overdrive prevents cancer response to dietary restriction 2Health News:Cell pathway on overdrive prevents cancer response to dietary restriction 3Health News:NewCourtland Network Plans to Transfer Ownership of Five Nursing Homes 2
(Date:5/5/2015)... - No one has covered cath labs ... - Primary research covering 700 angioplasty centres ... states & regions; hospital chains; govt. & pvt. hospitals ... stent market in India , which ... and Bio-Absorbable Stent (BVS), was valued above $400 million ...
(Date:5/4/2015)... Ill. , May 4, 2015  Landauer, Inc. ... and environmental radiation measurement and monitoring, outsourced medical physics ... it will release financial results for the fiscal second ... 11, 2015. The Company will also ... 11, 2015 at 4:00 p.m. Central Time (5:00 p.m. ...
(Date:5/4/2015)... -- BioSpecifics Technologies Corp. (NASDAQ: BSTC ), a biopharmaceutical ... XIAFLEX ® (collagenase clostridium histolyticum or CCH) in ... announce its first quarter 2015 financial results after the ... 11, 2015 and will host a conference call and ... May 12, 2015.  In order to ...
Breaking Medicine Technology:India Coronary Stent Market to be Tripled by 2021 2India Coronary Stent Market to be Tripled by 2021 3India Coronary Stent Market to be Tripled by 2021 4Landauer, Inc. Announces Date And Time For Announcement Of Fiscal Second Quarter 2015 Results And Conference Call 2BioSpecifics Technologies Corp. to Report First Quarter 2015 Financial Results on Monday, May 11, 2015 2
... TSX: BMR, TORONTO, July 10, 2007 /PRNewswire-FirstCall/ ... to the,development and commercialization of cancer therapies, ... independent team in,Basel, Switzerland validates tenascin as ... new treatments for glioblastoma,multiforme (GBM). , The ...
... 2007 - BusinessWeek,published an article on July ... companies to be first to bring to,market ... angiogenesis therapies are being pursued by,Sanofi-Aventis, Boston ... highlights a very promising new biological,therapy for ...
Cached Medicine Technology:Molecular Target of Bradmer's Neuradiab Further Validated by,Independent Findings 2Molecular Target of Bradmer's Neuradiab Further Validated by,Independent Findings 3Molecular Target of Bradmer's Neuradiab Further Validated by,Independent Findings 4BusinessWeek Article Highlights Promising Breakthrough Treatment,for Advanced Coronary Artery Disease 2
... Agarose, Molecular Biology Grade, is ... of nucleic acids. It can ... fragments from 0.2 to 40 ... Agarose is tested and certified ...
... is specifically formulated for high resolution of ... bp. This standard melting temperature agarose can ... 10 bp difference in size. UltraPure™ ... structure for better handling and improved clarity ...
Agarose IEF is suitable for isoelectric focusing of large molecules and is the gel of choice for many IEF applications and immunochemical detection methods....
Excellent multi purpose agarose Nuclease-free, Gel point (1.5%): 36 1.5 C, EEO: 0.05-0.13 Gel strength (1%): > 1200 g/cm 2 ....
Medicine Products: